Correspondence on: "Discrepancy in Spinal Muscular Atrophy Incidence findings in newborn screening programs: the influence of carrier screening?" by Kay et al

Affiliations

¹ Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, Liège, Belgium.
² Biochemical Genetics Laboratory, Human Genetics Department, University Hospital Liège & University of Liège, Liège, Belgium.
³ Molecular Genetics Laboratory, Human Genetics Department, University Hospital Liège & University of Liège, Liège, Belgium.
⁴ Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, Liège, Belgium. laurent.servais@paediatrics.ox.ac.uk.
⁵ MDUK Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK. laurent.servais@paediatrics.ox.ac.uk.

Free article

Comment

Tamara Dangouloff et al. Genet Med. 2020 Nov.

Free article

. 2020 Nov;22(11):1913-1914.

doi: 10.1038/s41436-020-0887-1. Epub 2020 Jun 30.

¹ Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, Liège, Belgium.
² Biochemical Genetics Laboratory, Human Genetics Department, University Hospital Liège & University of Liège, Liège, Belgium.
³ Molecular Genetics Laboratory, Human Genetics Department, University Hospital Liège & University of Liège, Liège, Belgium.
⁴ Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, Liège, Belgium. laurent.servais@paediatrics.ox.ac.uk.
⁵ MDUK Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK. laurent.servais@paediatrics.ox.ac.uk.

No abstract available

Comment on

Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
Kay DM, Stevens CF, Parker A, Saavedra-Matiz CA, Sack V, Chung WK, Chiriboga CA, Engelstad K, Laureta E, Farooq O, Ciafaloni E, Lee BH, Malek S, Treidler S, Anziska Y, Delfiner L, Sakonju A, Caggana M. Kay DM, et al. Genet Med. 2020 Aug;22(8):1296-1302. doi: 10.1038/s41436-020-0824-3. Epub 2020 May 18. Genet Med. 2020. PMID: 32418989

1. Kay DM, et al. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy. Genet Med. 2020 May 18; https://doi.org/10.1038/s41436-020-0824-3 [Epub ahead of print].
1. Kraszewski JN, et al. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state. Genet Med. 2018;20:608–613.
1. Dangouloff T, Burghes A, Tizzano EF, Servais L, NBS SMA Study Group. 244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10–12, 2019, Hoofdorp, The Netherlands. Neuromuscul Disord. 2020;30:93–103. - PubMed - PMC
1. Kariyawasam DST, Russell JS, Wiley V, et al. The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Genet Med. 2020;22:557–565. - PubMed - PMC
1. Vill K, et al. One year of newborn screening for SMA—results of a German pilot project. J Neuromuscul Dis. 2019;6:503–515. - PubMed - PMC